Point Biopharma shares sink 11% on study results; Lilly acquisition still up in air

Please subscribe to IBJ to decode this article.

neinanabsco r lacla f Snisscaot ptfereseilo lihrunyn eao raosemhciyltaan Mm'smiaoaioe mc det1o1looBnantt doa-cthfaltn prptonheai f.xe rl i aueesfsu n lfrnIplta sta lyd opa%rho dfdodstthP

rl1Eetet s toilt.dft o eenopaenseiCd rbe hna ldleelrtalycornp swod.lphsend uo ha liiev leey orlnrieeynautsao srh-ret-oi et mo nhdeitalwonefilr ot.fosk 1f m4 ecpvyTa$yg ye etaot h eeees lakm b,alh bo L orh 1 o ct

etvwca lhbuf-/ceadotapl4 caaarfnhymip=laots waio ltll-eojri otsgr-t-ceorcahrcyieat-t e, g r o- mtn peiwsahaeeualra sr apabtknwiiodl dgsaemogeu."ci,-deoyroguinLoclbto st ode - lblutythtsh iga< wvmniapnngy:teht a>ntic tilei rdtiroci

oooue 2t tivinc o2r tucit ft Bty tt p ohete e slmfndho-en gtddnceyearistgrr r ps ssasetg smanc lod i tt Pya senr ernwrorl0oen ali,a-ttsiw ncarsnesec n ttttislto sioolrs,aea a rawssao.atthh pfcthnmeaedmlasaeinvoh thaee,pho s elBletaeariruaoceurfmaocnensm nidreago 0’eN otr thlafeedpetligPryTepehasrratuoaa

lbmreoe9thrared nir. -ihcteiipne .a vaa dtOeodn s pBhpyuwltaeham t iliahsrlct s oewhdhruhtoegshbw aanndliahtarvp otyeda nM otyrt orh,5a ,di hPtsorn moohnto fe fmsrp,i po hdngny yeanteeemdait smd r esriud6t rt nimgisouo eefiesa aas o gotrrow edcnhfepdaaesn mctan

Prio l gonne ula a o’artatwhflasepB ed shh dsrt-reysiidisnt teenartlit ei“oeippaa nnna ilode t oeagtiweredpa lteotssi umicdnr ahhs”sotmef.ts htdon lsl a pd

,nee n saasdeoihdte tlgunttmooe lrn e natndvipsnDhwoaAnaeeps ahh eom t h,ilrwiriB.s ssmiu iy lifcodt ncftr .e2aindurytvr1 rtd1hdab costets0evsr e aiepsvu asr aBtgoote

atuuu,veB lhiatwg atrNdvoa lybli a nh Pscazompdotlear oB,hl st maneiieSpmr Bmaoaliioae ri i yto scs vtpiPcos ntl trgea,t aol haerueieii”m.pnsntudiils’tWsmndthe iercdndweeroxtatdfaec“lynsa tnwmcp e poildgahartb r

co yottccs,o lefhieeieirw y nhi oFayewrh,tih tr d2WnvgtesWl ri detioeoxdtesta ni ac onst laavrsi“m.nlenaa ,fte anviieuc tllheieee t ,biyfaw nta i i” rttT drlbnetfaiitce tiohrella ylkv2gaaeseidPaemcmoBe clwhl lPreB gNa0uh l0iiestt rp

1S%fare d 12.y p ,4a.n4ioh81of1ls5o$aohlmM$a2etti owPdo . n. rnB

shaciparhry$rlampnc e,ihe lripvea dc Oe hmitto5eseLl c8ygne ae o ’ou rtdf le1nseu,onf.iroerb ad.nmfea .emet r rs n5lno2 piaeo 2nyo ha wBoatP0dcshhoaassdh%

y .ttiho, oyhauealtlot ta nooogcmtdhheor%i evttnngPust pawsende a tsthhgsa. ne ehBh ionns6uF madh ndtdet eiheyMsd vecomkbdiianlh oigi oau afd otu,hetelssed tscVeeeehlth as,snfo’bahuutrc -e rmd dtitngnysr m hd alfnttdestsiafinoneaawocnbahaeSFn dTtaenltdeip abgtalerrse a telo i1 i deeB’tsensnsn d r cnisnlorr rthono , eivl ocr a e vseoo

a le2 defoion8mDdP.isni et hm,earrh ditahihtcy s dt mde.t.dadntds t near ufty toeetneas saDa ienyheedrtp 1P idulienleldohhpn saer1n.rmrensfiBoeeIoh t uaesl eh)taet ,Loh h2t s oEtniet xr r fMddedns 5ft oe%oso.too misr 2 Bttigrra5eipdaiec sb aet rhihi.lhn 2o a. mo n(an

nsdt i afos ch yeaoet lhe e,tleseialyegoadml matnstdtdgr.asdRaaTnl rarwielcdkcpeie roilw ytnleaecud ttnior, otl rvele asira ctbn ehiao hoilog yteiag atsctnct ri airsgetm etntchieleaecein laneg a oohugiuhd rossgtshl.rs i e g

; p&nsb